Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcriptional Profiling of human pluripotent stem cells and and derived tissues

ABSTRACT: Transcriptional Profiling of human pluripotent stem cells and and derived tissues

PROVIDER: PRJEB7972 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR699625.fastq.gz	Fastqsanger.gz
	ERR699626.fastq.gz	Fastqsanger.gz
	ERR699627.fastq.gz	Fastqsanger.gz
	ERR699628.fastq.gz	Fastqsanger.gz
	ERR699629.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 9

Similar Datasets

Transcriptional Profiling of human pluripotent stem cells and and derived tissues

Project description:RNAseq was carried out to compare global transcriptional profiles of human pluripotent H9 stem cells with tissues derived from these cells through directed differentiation, including endoderm and human intestinal organoids.

2015-03-09 | E-MTAB-3158 | biostudies-arrayexpress

Pluripotent stem cell derived models of neurological diseases reveal early transcriptional heterogeneity

Project description:Pluripotent stem cell derived models of neurological diseases reveal early transcriptional heterogeneity

| PRJNA576257 | ENA

Pluripotent stem cell derived models of neurological diseases reveal early transcriptional heterogeneity

Project description:Identification of transcriptional heterogeneity changes in Huntington's disease (HD) and Autism Spectrum Disorder (ASD) human embryonic stem cells(hESC)- and induced pluripotent stem cells(iPSC)-derived neural progenitor cells

2021-02-14 | GSE138525 | GEO

Progerin-induced transcriptional changes in Huntington's disease human pluripotent stem cells-derived neurons

Project description:Identification of transcriptional changes in Huntington's disease (HD) and normal (WT) human embryonic stem cells (hESC)- and induced pluripotent stem cells(iPSC)-derived striatal GABAergic neruons.

2020-01-01 | GSE111622 | GEO

Functionally Integrated Top-down Proteomics for Standardized Assessment of Human Induced Pluripotent Stem Cell-derived Engineered Cardiac Tissues

Project description:3-dimensional (3D) human induced pluripotent stem cell-derived engineered cardiac tissues (hiPSC-ECTs) have emerged as a promising alternative to 2-dimensional hiPSC-cardiomyocyte monolayer systems because hiPSC-ECTs are a closer representation of endogenous cardiac tissues and more faithfully reflect the relevant cardiac pathophysiology. The ability to perform functional and molecular assessments using the same hiPSC-ECT construct would allow for more reliable correlation between observed functional performance and underlying molecular events, and thus is critically needed. Herein, for the first time, we have established an integrated method that permits sequential assessment of functional properties and top-down proteomics from the same single hiPSC-ECT construct. We quantitatively determined the differences in isometric twitch force and the sarcomeric proteoforms between two groups of hiPSC-ECTs that differed in the duration of time of 3D-ECT culture. Importantly, by using this integrated method we discovered a new and strong correlation between the measured contractile parameters and the phosphorylation levels of alpha-tropomyosin between the two groups of hiPSC-ECTs. The integration of functional assessments together with molecular characterization by top-down proteomics in the same hiPSC-ECT construct enables a holistic analysis of hiPSC-ECTs to accelerate their applications in disease modeling, cardiotoxicity, and drug discovery.

2021-01-07 | PXD022814 | Pride

Progerin-induced transcriptional changes in Huntington's disease human pluripotent stem cells-derived neurons

Project description:Progerin-induced transcriptional changes in Huntington's disease human pluripotent stem cells-derived neurons

| PRJNA437589 | ENA

Cell surface n-glycoproteins on human pluripotent stem cell derived hepatic endoderm

Project description:Cell surface capture technology data from human pluripotent stem cell derived hepatic endoderm at day 10 of differentiation

2016-10-03 | MSV000080215 | MassIVE

human induced pluripotent stem cell-derived cardiomyocytes

Project description:human induced pluripotent stem cell-derived cardiomyocytes

| PRJNA1005254 | ENA

Transcriptional profiling of stem cell-derived polarized hepatocytes

Project description:Transcriptional profiling of stem cell-derived polarized hepatocytes

| PRJNA508790 | ENA

Metabolomics Identifies Metabolic Markers of Maturation in Human Pluripotent Stem Cell-Derived Cardiomyocytes

Project description:Cardiovascular disease is a leading cause of death worldwide. Human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) hold immense clinical potential and recent studies have enabled generation of virtually pure hPSC-CMs with high efficiency in chemically defined and xeno-free conditions. Despite these advances, hPSC-CMs exhibit an immature phenotype and are arrhythmogenic in vivo, necessitating development of methods to mature these cells. hPSC-CMs undergo significant metabolic alterations during differentiation and maturation. A detailed analysis of the metabolic changes accompanying maturation of hPSC-CMs may prove useful in identifying new strategies to expedite the maturation process and also provide biomarkers for testing or validating hPSC-CM maturation. In this study we identified global metabolic changes which take place during long-term culture and maturation of hPSC-CMs derived from three different hPSC lines. We have identified several metabolic pathways, including phospholipid metabolism and pantothenate and Coenzyme A metabolism, which showed significant enrichment upon maturation in addition to fatty acid oxidation and metabolism. We also identified an increase in glycerophosphocholine and reduction in phosphocholine as potential metabolic biomarkers of maturation. These biomarkers were also affected in a similar manner during murine heart development in vivo. These results support that hPSC-CM maturation is associated with extensive metabolic rewiring and understanding the role of these metabolic changes in maturation process has the potential to develop novel approaches to monitor and expedite hPSC-CM maturation.

2018-04-24 | MTBLS425 | MetaboLights

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data